1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-24-246 is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC).
This funding opportunity supports small businesses in conducting research and development that includes a clinical trial, with the potential for commercialization and impact on public health. It is relevant for developing and testing clinical decision support software for antimicrobial resistance stewardship. [20, 23, 27]
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: US-based, for-profit small businesses (no more than 500 employees and at least 51% owned and controlled by U.S. individuals). [20, 23]. Confirm the full requirements in the official notice before applying.
The current listing shows not specified (Budgets up to $306,872 total costs for Phase I and up to $2,045,816 total costs for Phase II for NIDA, with possible waivers for higher amounts across NIH institutes) [20, 27]. Verify award ceilings, matching requirements, and allowable costs in the official notice.
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-24-246 is funded by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation encourages small businesses to collaborate with non-profit research institutions on research and development projects related to the mission of NIH and CDC.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs (Omnibus/Parent Funding Opportunity Announcements) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). The NIH and CDC SBIR/STTR programs are one of the largest sources of early-stage capital for technology commercialization in the United States, enabling US-owned and operated small businesses to conduct research and development that has a strong potential for commercialization i…
CDC-RFA-EH-27-0074 posted as a forecast September 22, 2026: 6 expected awards at $750,000 to $900,000. That is flat funding against the expiring cycle — and the only proven way in is the consortium model Arizona used to bring three states under one award.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article